Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis - Top-Institutions - MDSpire

Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis

  • By

  • Huan Shao

  • Lingyun Zou

  • Xiaojiao Zhu

  • Yingding Ruan

  • Hongsheng Xue

  • May 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Trinity St. James’s Cancer Institute
    Trinity St. James’s Cancer Institute

    Dublin, Ireland

    Key Differentiators

    • Oncology

  • #2

    Trinity College Dublin
    Trinity College Dublin

    Dublin, Ireland

    Key Differentiators

    • Oncology

  • #3

    Hospital Universitario Puerta de Hierro Majadahonda
    Hospital Universitario Puerta de Hierro Majadahonda

    Majadahonda, Spain

    Key Differentiators

    • Oncology

  • #4

    Sun Yat-sen University Cancer Center
    Sun Yat-sen University Cancer Center

    Guangzhou, China

    Key Differentiators

    • Oncology

Original Source(s)

Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis

  • by Huan Shao, Lingyun Zou, Xiaojiao Zhu, Yingding Ruan, Hongsheng Xue

  • May 22, 2026

Related Content

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?